1. Home
  2. NNVC vs KAPA Comparison

NNVC vs KAPA Comparison

Compare NNVC & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • KAPA
  • Stock Information
  • Founded
  • NNVC 2005
  • KAPA 2013
  • Country
  • NNVC United States
  • KAPA United States
  • Employees
  • NNVC N/A
  • KAPA N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • KAPA
  • Sector
  • NNVC Health Care
  • KAPA
  • Exchange
  • NNVC Nasdaq
  • KAPA NYSE
  • Market Cap
  • NNVC 21.2M
  • KAPA 21.3M
  • IPO Year
  • NNVC N/A
  • KAPA 2024
  • Fundamental
  • Price
  • NNVC $1.47
  • KAPA $1.71
  • Analyst Decision
  • NNVC Strong Buy
  • KAPA Strong Buy
  • Analyst Count
  • NNVC 1
  • KAPA 1
  • Target Price
  • NNVC $6.50
  • KAPA $9.00
  • AVG Volume (30 Days)
  • NNVC 167.5K
  • KAPA 102.5K
  • Earning Date
  • NNVC 02-12-2025
  • KAPA 11-14-2024
  • Dividend Yield
  • NNVC N/A
  • KAPA N/A
  • EPS Growth
  • NNVC N/A
  • KAPA N/A
  • EPS
  • NNVC N/A
  • KAPA N/A
  • Revenue
  • NNVC N/A
  • KAPA N/A
  • Revenue This Year
  • NNVC N/A
  • KAPA N/A
  • Revenue Next Year
  • NNVC N/A
  • KAPA N/A
  • P/E Ratio
  • NNVC N/A
  • KAPA N/A
  • Revenue Growth
  • NNVC N/A
  • KAPA N/A
  • 52 Week Low
  • NNVC $1.00
  • KAPA $1.22
  • 52 Week High
  • NNVC $3.59
  • KAPA $4.00
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 60.22
  • KAPA N/A
  • Support Level
  • NNVC $1.42
  • KAPA N/A
  • Resistance Level
  • NNVC $1.57
  • KAPA N/A
  • Average True Range (ATR)
  • NNVC 0.07
  • KAPA 0.00
  • MACD
  • NNVC 0.01
  • KAPA 0.00
  • Stochastic Oscillator
  • NNVC 83.33
  • KAPA 0.00

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About KAPA KAIROS PHARMA LTD

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

Share on Social Networks: